MedTrace Logo

Aerosolized Liposomal Camptothecin in Patients With Metastatic or Recurrent Cancer of the Endometrium or the Lung

NCT00277082 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 24

Last updated 2010-01-07

No results posted yet for this study

Summary

To determine the concentration of 9-nitrocamptothecin (9NC) in the alveolar fluid over time.

1.2. To determine the arterial concentration of 9NC administered by inhalation in comparison to venous and urine concentrations.

1.3. To determine the tumor concentration of 9NC administered by inhalation

Conditions

Interventions

DRUG

9-NC in aerosol reservoir

Samples will be minced or centrifuged and L9NC extracted by chromatography. L9NC will be measured by HPLC or mass spectrometry

Sponsors & Collaborators

  • University of New Mexico

    lead OTHER

Principal Investigators

  • Claire Verschraegen, MD · University of New Mexico

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-08-31
Completion
2005-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00277082 on ClinicalTrials.gov